Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.3540
+0.0020 (0.57%)
At close: Dec 5, 2025
62.01%
Market Cap711.31M
Revenue (ttm)n/a
Net Income (ttm)-84.10M
Shares Out2.01B
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,977,098
Average Volume11,993,284
Open0.3515
Previous Close0.3520
Day's Range0.3310 - 0.3595
52-Week Range0.2000 - 1.1800
Beta1.88
RSI36.30
Earnings DateFeb 18, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Sector Healthcare
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.